JP2024505790A5 - - Google Patents

Info

Publication number
JP2024505790A5
JP2024505790A5 JP2023536875A JP2023536875A JP2024505790A5 JP 2024505790 A5 JP2024505790 A5 JP 2024505790A5 JP 2023536875 A JP2023536875 A JP 2023536875A JP 2023536875 A JP2023536875 A JP 2023536875A JP 2024505790 A5 JP2024505790 A5 JP 2024505790A5
Authority
JP
Japan
Prior art keywords
sequence
pharmaceutical composition
antibody
antigen
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023536875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024505790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/061926 external-priority patent/WO2022130318A2/en
Publication of JP2024505790A publication Critical patent/JP2024505790A/ja
Publication of JP2024505790A5 publication Critical patent/JP2024505790A5/ja
Pending legal-status Critical Current

Links

JP2023536875A 2020-12-18 2021-12-17 インテグリンアルファ11ベータ1に対する抗体 Pending JP2024505790A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063127849P 2020-12-18 2020-12-18
US63/127,849 2020-12-18
US202163213973P 2021-06-23 2021-06-23
US63/213,973 2021-06-23
PCT/IB2021/061926 WO2022130318A2 (en) 2020-12-18 2021-12-17 Antibodies against integrin alpha 11 beta 1

Publications (2)

Publication Number Publication Date
JP2024505790A JP2024505790A (ja) 2024-02-08
JP2024505790A5 true JP2024505790A5 (https=) 2024-12-25

Family

ID=79021748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536875A Pending JP2024505790A (ja) 2020-12-18 2021-12-17 インテグリンアルファ11ベータ1に対する抗体

Country Status (13)

Country Link
US (1) US20240317865A1 (https=)
EP (1) EP4263605A2 (https=)
JP (1) JP2024505790A (https=)
KR (1) KR20230121831A (https=)
AU (1) AU2021400221A1 (https=)
BR (1) BR112023011777A2 (https=)
CA (1) CA3205574A1 (https=)
CL (1) CL2023001757A1 (https=)
CO (1) CO2023008544A2 (https=)
IL (1) IL303741A (https=)
MX (1) MX2023007302A (https=)
TW (1) TW202241946A (https=)
WO (1) WO2022130318A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021127500A1 (en) 2019-12-20 2021-06-24 Momenta Pharmaceuticals, Inc. Antibodies against integrin alpha 11 beta 1

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79289A (en) 1985-07-05 1992-01-15 Whitehead Biomedical Inst Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
ATE117375T1 (de) 1987-09-11 1995-02-15 Whitehead Biomedical Inst Transduktionsveränderte fibroblasten und ihre anwendung.
JP2914692B2 (ja) 1987-12-11 1999-07-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 内皮細胞の遺伝子修飾
WO1989007136A2 (en) 1988-02-05 1989-08-10 Whitehead Institute For Biomedical Research Modified hepatocytes and uses therefor
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2096750T3 (es) 1990-10-31 1997-03-16 Somatix Therapy Corp Vectores retroviricos utiles para la terapia genica.
SE9201984D0 (sv) 1992-06-29 1992-06-29 Pharmacia Biosensor Ab Improvement in optical assays
US5308341A (en) 1993-09-28 1994-05-03 Becton, Dickinson And Company Method of testing the dose accuracy of a medication delivery device
US6146361A (en) 1996-09-26 2000-11-14 Becton Dickinson And Company Medication delivery pen having a 31 gauge needle
US6302855B1 (en) 1998-05-20 2001-10-16 Novo Nordisk A/S Medical apparatus for use by a patient for medical self treatment of diabetes
US6192891B1 (en) 1999-04-26 2001-02-27 Becton Dickinson And Company Integrated system including medication delivery pen, blood monitoring device, and lancer
US6277099B1 (en) 1999-08-06 2001-08-21 Becton, Dickinson And Company Medication delivery pen
WO2003022330A2 (en) 2001-09-12 2003-03-20 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
FR2849436B1 (fr) 2002-12-27 2007-01-05 Patrick Frayssinet Particules et ceramiques de phosphates de calcium pour transfection in vivo et in vitro
EP3524625A1 (en) * 2018-02-08 2019-08-14 Bergen Teknologioverforing AS Antibody against alpha-11 integrin and its use
EP3760722A4 (en) * 2018-03-01 2021-11-24 Hiroshima University MONOCLONAL ANTI-INTEGRIN ALPHA11 ANTIBODY AND USES THEREOF
WO2021127500A1 (en) * 2019-12-20 2021-06-24 Momenta Pharmaceuticals, Inc. Antibodies against integrin alpha 11 beta 1

Similar Documents

Publication Publication Date Title
JP2006516409A5 (https=)
RU2019118359A (ru) Антитело к cd73 человека
HRP20120376T1 (hr) Nova protutijela protiv il-13 i njihove upotrebe
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2020152735A5 (https=)
JP2022023051A (ja) 瘻孔を伴うクローン病の治療用ベドリズマブ
JP2019522961A5 (https=)
JP2009537608A5 (https=)
JP2018108081A5 (https=)
CN112409488B (zh) 针对多种冠状病毒的单克隆抗体及应用
CN106103479B (zh) 识别其它ccr3-结合趋化因子的抗嗜酸粒细胞趋化因子-2抗体
HRP20170407T1 (hr) Anti-epha2 anitijelo
JP2010516229A5 (https=)
JP2012504955A5 (https=)
JP2011528902A5 (https=)
JP2022538232A5 (https=)
CN110483637B (zh) 一种抗禽流感病毒神经氨酸酶n2单克隆抗体、编码基因及其应用
JPWO2023026791A5 (https=)
JPWO2020059847A5 (https=)
RU2008140947A (ru) Антитела к egfl7 и способы их применения
JP2026001077A5 (https=)
JP2022502024A5 (https=)
JP2019528046A5 (https=)
JP2024505790A5 (https=)
JP2020522535A5 (https=)